期刊
CLINICS IN CHEST MEDICINE
卷 28, 期 1, 页码 23-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.ccm.2006.11.010
关键词
-
资金
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL077805, R01HL083491, P01HL066254, P50HL073994] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016285] Funding Source: NIH RePORTER
- NHLBI NIH HHS [P50 HL073994, R21 HL077805, P01 HL066254, R01 1HL083491, P01HL66254, R01 HL083491] Funding Source: Medline
- NIEHS NIH HHS [R01 ES016285] Funding Source: Medline
The secondary role of pathology in the present clinical management of pulmonary hypertension (PH) reflects to some extent the limitations of the current understanding of the disease. Ample room exists for the diagnostic translation of the pathobiologic studies, with the goal of improving the diagnostic and prognostic power of the pathologic assessment of pulmonary vascular remodeling. This article seeks to show the complementarities of the pathology and pathobiology of PH.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据
分享论文
